APP, a protein commonly associated with Alzheimer's disease, plays a vital role in learning, memory, and social behavior in the developing brain, a new mouse study finds.
Researchers use a novel genomic approach to better understand genetic mutations associated with familial Alzheimer's disease.
A new study reports researchers have successfully reversed memory loss in fly models of Alzheimer's disease by restoring the balance between to enzymes that regulate gene expression.
A new drug has proven effective at restoring memories and neural connections in mouse models of Alzheimer's disease. The new drug was originally developed as a treatment for Schizophrenia. While the drug does not destroy amyloid plaques associated with Alzheimer's, it does allow the plaques to co-exist with neurons.
Using a technique called parabiosis on pairs of mice, researchers discover what they call 'cancer like mobility' of amyloid beta, reporting it can travel to the brain from other parts of the body.
Researchers reveal how two classes of drug compounds, which are currently in trial, work to fight Alzheimer's disease. They also identify possible causes of early onset hereditary forms of AD.
Researchers report they may have discovered the signature of blast neurotrauma.
Researchers report specific alterations in signaling circuits associated with memory can induce an abnormal response in neurons, which is linked to the aging process and cognitive decline.
A new study reports the dementia associated with Down syndrome involves defects in GSAP, which also malfunctions in Alzheimer's disease.
According to a new Journal of Alzheimer's Disease study, common genetic variants in amyloid precursor protein are associated with fluid intelligence in children.
The chemical EPPS appears to effectively restore memory and remove the build up of amyloid in the brains of mice genetically altered to have features of Alzheimer's disease.